维普期刊资源整合服务平台（V6.5）

38篇 您的检索式：作者名="Ashcroft DM"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti-tumor necrosis factor显示文摘	Saad AA Ashcroft DM Watson KD		0，，03：	1
2	Safety culture assessment in community pharmacy: development, face validity, and feasibility of the manchester patient safe- ty assessment framework显示文摘	Ashcroft DM Morecroft C Parker D	2005	Qual Saf Health Care2005，14，6：	1
3	Persistence with antitumour necrosis factor therapies in patients with psoriatic arthritis:observational study from the British Society of Rheumatology Biologics Register显示文摘	Saad AA Ashcroft DM Watson KD		0，，02：	1
4	Therapeutic interventions for vitiligo显示文摘	Whitton ME Ashcroft DM Gonzlez U	2008	J Am Acad Dermatol2008，59，4：	1
5	Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: Meta-analysis of randomised controlled trials显示文摘	Ashcroft DM Dimmock P Garside R	2005	BMJ2005，330，7490：	1
6	Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality 显示文摘	Ashcroft DM Wan Po AL Williams HC	1999	Br J Dermatol1999，141，2：	1
7	Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis:meta-analysis of randomised controlled trials显示文摘	Ashcroft DM Dimmock P Garside R	2005	BMJ2005，330，7490：	1
8	Systematic review of the analgesic efficacy and tolerability of COX-2 inhibitors in postoperative pain control显示文摘	Chert LC Elliott RA Ashcroft DM	2004	J Clin Pharm Ther2004，29，3：	1
9	Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials显示文摘	Ashcroft DM Dimmock P Garside R	2005	Br Med J2005，330，7490：	1
10	Clinical measures of disease severity and outcome in psoriasis:a critical appraisal of their quality显示文摘	Ashcroft DM Wan Po AL Williams HC	1999	Br J Dermatol1999，141，2：	1
11	Risk of myocardial infarction associated with selective Cox-2 inhibitors: meta-analysis of randomised controlled trials显示文摘	Chen LC Ashcroft DM	2007	Pharmacoepidemiol Drug Saf2007，16，：	1
12	Therapeutic interventions for vitiligo 显示文摘	Whitton ME Ashcroft DM Gonzalez U	2008	J Am Acad Dermatol2008，59，4：	1
13	Clinical measures of disease severity and outcome in psoriasis:a critical appraisal of their quality显示文摘	Ashcroft DM Wan Po AL Williams HC	1999	Br J Dermatol1999，141，2：	1
14	Risk of myocardial infarction associated with selective COX-2 inhibitors: meta-anMysis of randomised controlled trims显示文摘	Chen LC Ashcroft DM	2007	Pharmacoepidemiol Drag Saf2007，16，：	1
15	Clinical measures of disease severity and outcome on psoriasis:acritical appraisal of the quality显示文摘	Ashcroft DM Wanpo L Williams HC	1999	Br J Dermatol1999，141，2：	1
16	Herbal Remedies:Issues in Licensing and Economic Evaluation显示文摘	Ashcroft DM Li Wan Po A	1999	Pharmacoeconomics1999，16，4：	1
17	Hospital admissions associated with adverse drug reactions:a systematic review of prospective observational studies显示文摘	Kongkaew C Noyce PR Ashcroft DM	2008	Ann Pharmacother2008，42，7：	1
18	Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality显示文摘	Ashcroft DM Wan Po AL Williams HC	1999	Br J Dermatol1999，141，2：	1
19	Balancing the benefits and risks of drug treatment: a stated-preference, discrete choice experiment with patients with psoriasis 显示文摘	Seston EN Ashcroft DM Griffiths CE	2007	Arch Dermatol2007，143，9：	1
20	Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti-tumor necrosis factor therapies显示文摘	Saad AA Ashcroft DM Watson KD	2010	Arthritis Care Res (Hoboken)2010，62，3：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示